CORD, LLC Completes One-Year Follow-Up on Subjects From the Model SC9 Intraocular Lens FDA Clinical Trial

ALISO VIEJO, Calif.: ALISO VIEJO, Calif., Nov. 11, 2021 /PRNewswire/ -- CORD, LLC, a privately held ophthalmic medical device company, today announced results from its one-year follow-up on patients who were implanted with the Model SC9 intraocular lens (IOL) in a clinical trial. The trial was performed under an Investigational...

Click to view original post